Booklet Provides Guidance on Appointing or Being a Health Care Proxy

Publication
Article
OncologyONCOLOGY Vol 12 No 12
Volume 12
Issue 12

Choice In Dying (Washington, DC) recently released a new booklet entitled, “Healthcare Agents: Appointing and Being One,” intended to serve as a reference when appointing a health care agent (proxy) or acting as one.

Choice In Dying (Washington, DC) recently released a new booklet entitled, “Healthcare Agents: Appointing and Being One,” intended to serve as a reference when appointing a health care agent (proxy) or acting as one. Providing answers to common questions and highlighting difficult topics everyone should consider, the new booklet helps individuals select agents who will be successful advocates and also helps reduce agents’ uncertainty over which decisions best reflect the patients’ wishes.

Among other important issues, the booklet urges people to talk with family members and agents about medical treatment decisions and personal values as a way to ensure that their dignity and quality of life will be respected. People should not assume that their closest relatives would automatically want to be agents or will know their wishes, the booklet warns.

The thoughtful appointment of a health care agent is one of the best ways to ensure that end-of-life medical care decisions are heard, understood, and honored. “Instead of seeing end-of-life decisions as a blank canvas on which others will paint, put the paint brush in your own hands. Appoint a proxy and paint a picture of the life you want to live up to the last minute. Protect your choices and at the same time protect your family from the emotional anguish and conflict of not knowing your wishes. That is the best gift you can give them,” said Dr. Karen Kaplan, executive director of Choice In Dying.

Recent Videos
Daniel Peters, MD, aims to reduce the toxicity associated with AML treatments while also improving therapeutic outcomes.
Numerous clinical trials vindicating the addition of immunotherapy to first-line chemotherapy in SCLC have emerged over the last several years.
Patients with AML will experience different toxicities based on the treatment they receive, whether it is intensive chemotherapy or targeted therapy.
A younger patient with AML who is more fit may be eligible for different treatments than an older patient with chronic medical conditions.
Breast cancer care providers make it a goal to manage the adverse effects that patients with breast cancer experience to minimize the burden of treatment.
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Genetic backgrounds and ancestry may hold clues for better understanding pancreatic cancer, which may subsequently mitigate different disparities.
Factors like genetic mutations and smoking may represent red flags in pancreatic cancer detection, said Jose G. Trevino, II, MD, FACS.
Thomas Hope, MD, believes that an NRC initiative to update infiltration guidelines may organically address concerns that H.R. 2541 outlines.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
Related Content